BellaSeno GmbH, an ISO 13485-certified medtech firm creating resorbable scaffolds utilizing additive manufacturing applied sciences, in the present day introduced that Prof. Anand Deva offered new scientific information on BellaSeno’s novel, 3D printed, resorbable breast scaffolds at The Aesthetic MEET 2025 convention in Austin, TX, USA.
In an Australian scientific trial initiated in 2022, 19 sufferers acquired BellaSeno’s resorbable, polycaprolactone-based breast scaffolds following the removing of failed silicone breast implants. The outcomes of a one-year follow-up examination confirmed 87% breast quantity retention, low complication charges, prime quality of life, pure softness, and enhancements in bodily and psychological well-being. Furthermore, not one of the issues related to silicone implants or fats grafting (e.g., capsular contractures, infections, necrosis, calcification, oil cysts, or scaffold removals) have been recorded. For sufferers reaching the two-year mark, Prof. Deva and his crew noticed profitable vascularization and vessel community formation within the newly fashioned breast tissue inside the scaffold.
“These scientific findings show that BellaSeno has developed a secure, high-performance various to silicone breast implants,” mentioned Prof. Deva. “BellaSeno’s implants improve and defend the physique’s regenerative potential, changing and/or augmenting like tissue with like tissue.”
“That is one other milestone demonstrating that our pioneering method presents a risk-optimized, high-quality answer for sufferers who’ve skilled issues associated to silicone breast implants, promising them a pure various,” mentioned Mohit Chhaya, CEO of BellaSeno. “Our scaffolds enabled the breasts to take care of their form, quantity and kind over time and achieved softness, one other essential efficiency measure.”
Professor Anand Deva is the Self-discipline head of Beauty, Plastic and Reconstructive Surgical procedure at Macquarie College, Australia, and the founding father of Built-in Breast Well being Clinics by way of partnerships with authorities and business. He’s dedicated to scientific innovation and translational analysis, with the purpose of bettering scientific follow and affected person outcomes.
BellaSeno GmbH was based in 2015 and is headquartered on the BioCity campus in Leipzig, Germany, with a subsidiary in Brisbane, Australia. The Firm is creating novel resorbable tender tissue and bone reconstruction implants made by additive manufacturing (3D printing) underneath ISO 13485 certification.
The Firm has acquired substantial monetary assist from non-public traders in addition to from the Saxony Improvement Financial institution (SAB), the European Fund for Regional Improvement (EFRE), Germany´s Federal Ministry of Schooling and Analysis (BMBF) and the Australian authorities. The Firm has been co-funded from tax assets based mostly on the price range adopted by the members of Saxony State Parliament.
